- Home
- TRNR vs SNOA Comparison
TRNR vs SNOA Comparison
Compare TRNR & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNR
- SNOA
- Stock Information
- Founded
- TRNR 2017
- SNOA 1999
- Country
- TRNR United States
- SNOA United States
- Employees
- TRNR N/A
- SNOA N/A
- Industry
- TRNR Consumer Electronics/Appliances
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- TRNR Technology
- SNOA Health Care
- Exchange
- TRNR Nasdaq
- SNOA Nasdaq
- Market Cap
- TRNR 3.9M
- SNOA 3.6M
- IPO Year
- TRNR 2023
- SNOA 2007
- Fundamental
- Price
- TRNR $1.44
- SNOA $3.51
- Analyst Decision
- TRNR
- SNOA
- Analyst Count
- TRNR 0
- SNOA 0
- Target Price
- TRNR N/A
- SNOA N/A
- AVG Volume (30 Days)
- TRNR 36.3M
- SNOA 4.4M
- Earning Date
- TRNR 03-31-2025
- SNOA 02-05-2025
- Dividend Yield
- TRNR N/A
- SNOA N/A
- EPS Growth
- TRNR N/A
- SNOA N/A
- EPS
- TRNR N/A
- SNOA N/A
- Revenue
- TRNR $3,180,000.00
- SNOA $13,973,000.00
- Revenue This Year
- TRNR $1,543.45
- SNOA $23.89
- Revenue Next Year
- TRNR $54.84
- SNOA $25.45
- P/E Ratio
- TRNR N/A
- SNOA N/A
- Revenue Growth
- TRNR 226.82
- SNOA 13.51
- 52 Week Low
- TRNR $0.86
- SNOA $1.90
- 52 Week High
- TRNR $1,640.00
- SNOA $9.40
- Technical
- Relative Strength Index (RSI)
- TRNR 44.05
- SNOA 75.44
- Support Level
- TRNR $2.13
- SNOA $1.90
- Resistance Level
- TRNR $3.96
- SNOA $4.46
- Average True Range (ATR)
- TRNR 0.67
- SNOA 0.35
- MACD
- TRNR 0.07
- SNOA 0.14
- Stochastic Oscillator
- TRNR 21.74
- SNOA 62.89
About TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.